Medicamen Biotech fundamental analysis

MEDICAMEQ

267.3

5.40 (-1.98%)
Last updated on 3 Jun, 2026 | 14:48 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Medicamen Biotech Fundamentals

P/E Ratio

37.98

P/B Ratio

1.36

Div. Yield

0.37

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 37.98, compared to the sector average of 69.94. Its P/B Ratio stands at 1.36, while the sector’s is 2.97. In terms of returns, the stock offers a Dividend Yield of 0.37%, which is than the sector’s 0.55%.

Medicamen Biotech Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Average

On its scorecard, Medicamen Biotech reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost